AbbVie Profile

USD 1.19  1.01%

Sale by Richard Gonzalez of 4400 shares of AbbVie

AbbVie Inc insider trading alert for sale of common stock $0.01 par value by Richard Gonzalez, Chairman of the Board and CEO, on February 24, 2018. This event was filed by Abbvie Inc with SEC on 2016-06-03. Statement of changes in beneficial ownership - SEC Form 4. Richard Gonzalez is currently serves as chairman, ceo and chairman of executive committee of AbbVie Inc [view details]   

AbbVie Summary

AbbVie Inc (ABBV) is traded on New York Stock Exchange in USA. It is located in ILLINOIS, U.S.A and employs 29,000 people. AbbVie is listed under Pharmaceutical Products category by Fama And French industry classification.The company currently falls under 'Mega-Cap' category with current market capitalization of 188.57 B. AbbVie Inc conducts business under Healthcare sector and is part of Pharmaceuticals And Biosciences industry. This company has 1.59 B outstanding shares of which 15.15 M shares are presently shorted by private and institutional investors with about 2.3 trading days to cover. AbbVie Inc. Commo currently holds about 9.79 B in cash with 6.45 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.16.
Check AbbVie Probability Of Bankruptcy

Ownership Allocation (%)

Top Holders

Major Institutional Holders

InstituionSecurity TypeTotal SharesValue
Capital Research Global InvestorsCommon Shares193 M18.7 B
Vanguard Group IncCommon Shares119.9 M11.6 B
View AbbVie Diagnostics

Selected AbbVie Inc Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Net Income    

Key Fundamentals

AbbVie Against Markets

Risk Adjusted
Performance Score (0 to 100)
Chance of
Financial Distress (0 to 100%)
< 28% 
Equity ratings for AbbVie Inc are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceutical products worldwide. The company was incorporated in 2012 and is based in North Chicago, Illinois. AbbVie operates under Drug Manufacturers - Major classification in USA and traded on New York Stock Exchange exchange. It employs 29000 people. more
Fama & French Pharmaceutical Products
Pharmaceutical Products
Fama & French Classification
NameAbbVie Inc
ChairmanRichard GonzalezAll Leadership
Analyst Consensus
Piotroski F Score
Macroaxis Advice
Bond Rating
Healthcare, Pharmaceuticals And Biosciences
InstrumentUSA Stock Stocks Directory
RegionNorth America
Business Address1 North Waukegan Road
Foreign Associates
ExchangeNew York Stock Exchange
CIK Number01551152.0
IndustryPharmaceuticals And Biosciences
Contact Number847 932 7900
CurrencyUSD - US Dollar


AbbVie Analyst Recommendations
Target PriceAdvice# of Analysts
AbbVie Inc current and past analyst recommendations published by number of research institutions as well as average analyst consensus
AbbVie Analyst Advice  


Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Investing Ideas  


AbbVie Earnings Estimates
EPSEstimate Date
Quarterly Estimate1.26April 27, 2017
AbbVie Inc normalized analysts earnings estimates for actual as well as projected forward EPS values taken as an average expert opinion over time
Earnings Estimate  


AbbVie Corporate Directors
Frederick Waddell Independent Director
Robert Alpern Independent Director
Glenn Tilton Independent Director